Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02065622
Brief Title: Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

First Submitted : February 17, 2014
First Submitted that Met QC Criteria : February 17, 2014
First Posted : February 19, 2014 (Estimate)

Results First Submitted : August 19, 2020
Results First Submitted that Met QC Criteria : September 15, 2020
Results First Posted : October 8, 2020

Last Update Submitted that Met QC Criteria : November 19, 2020
Last Update Posted : November 23, 2020